Bayesian Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bayesian Capital Management’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,657	Closed	-$316K	–	1190
2023 Q4	$316K	Sell	1,657 -3,099	-65%	-$586K	0.03%	491
2023 Q3	$947K	Buy	+4,756	New	+$1.12M	0.11%	238
2023 Q2	–	Sell	-9,047	Closed	-$1.96M	–	1129
2023 Q1	$1.96M	Buy	+9,047	New	+$1.76M	0.24%	113
2022 Q4	–	Sell	-2,005	Closed	-$558K	–	1086
2022 Q3	$558K	Buy	+2,005	New	+$510K	0.11%	253
2022 Q2	–	Sell	-7,145	Closed	-$1.48M	–	1159
2022 Q1	$1.48M	Buy	+7,145	New	+$1.18M	0.22%	121

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bayesian Capital Management's SWAV Position: Q1 2024 in Review

Bayesian Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 1,657 shares — an estimated $316K sold.

Bayesian Capital Management first reported a position in SWAV in Q1 2022 and held it in 5 quarters. The position peaked at $1.96M in Q1 2023. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

Bayesian Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Bayesian Capital Management sold 1,657 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $316K.
Bayesian Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Bayesian Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $1.96M in Q1 2023.
488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on Bayesian Capital Management's 13F filing for Q1 2024, filed 15 May 2024.